AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Acadia Pharmaceuticals Inc.
$20.59
-$5.70 (-21.68%)
Previous Close
$20.76
Day Range
$20.49$21.01
Year Range
$18.39$30.96
Market Cap
3.55B
AVG Volume
1.82M
Trailing/Forward PE
9.15/21.95
PEG ratio
-0.4
Dividend Yield
-
Next Earnings Date
2026-11-04
Primary Exchange
NASDAQ
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Earnings: ACAD
Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 4 Nov 2026.
Video analysis: ACAD
All videosNo video analysis for this stock yet. Request one from our team.
News: ACAD
Similar companies
-
Axsome Therapeutics, Inc.
AXSM
·
NASDAQ
Compare
-
Vanda Pharmaceuticals Inc.
VNDA
·
NASDAQ
Compare
-
Praxis Precision Medicines, Inc.
PRAX
·
NASDAQ
Compare
-
Neumora Therapeutics, Inc. Common Stock
NMRA
·
NASDAQ
Compare
-
Rapport Therapeutics, Inc. Common Stock
RAPP
·
NASDAQ
Compare
-
Anavex Life Sciences Corp.
AVXL
·
NASDAQ
Compare